Table 5.
Effect of clinical, pathological and immunohistochemical factors that may affect the sonographic features of TN invasive breast carcinoma. Data are presented as frequency (%).
| Shape | Angular/spiculated margin | Posterior acoustic enhancement | Calcifications | |||||
|---|---|---|---|---|---|---|---|---|
| Regular | Irregular | Yes | No | Yes | No | Yes | No | |
| Age | ||||||||
| <45 yrs | 8 (28.6) | 20 (71.4) | 2 (7.1) | 26 (92.9) | 12 (42.9) | 16 (57.1) | 4 (14.3) | 24 (85.7) |
| 45–60 yrs | 16 (33.3) | 32 (66.7) | 8 (16.7) | 40 (83.3) | 16 (33.3) | 32 (66.7) | 10 (20.8) | 38 (79.2) |
| >60 yrs | 7 (25) | 21 (75) | 8 (28.6) | 20 (71.4) | 5 (17.9) | 23 (82.1) | 8 (28.6) | 20 (71.4) |
| P value | 0.735 | 0.104 | 0.126 | 0.423 | ||||
| Tumor size | ||||||||
| <2 cm | 13 (30.2) | 30 (69.8) | 4 (9.3) | 39 (90.7) | 14 (32.6) | 29 (67.4) | 9 (20.9) | 34 (79.1) |
| 2–5 cm | 18 (30) | 42 (70) | 14 (23.3) | 46 (76.7) | 18 (30) | 42 (70) | 13 (21.7) | 47 (78.3) |
| >5 cm | 0 (0) | 1 (100) | 0 (0) | 1 (100) | 1 (100) | 0 (0) | 0 (0) | 1 (100) |
| P value | 0.807 | 0.161 | 0.325 | 0.87 | ||||
| Pathological grade | ||||||||
| Low | 1 (5.6) | 17 (94.4) | 4 (22.2) | 14 (77.8) | 6 (33.3) | 12 (67.7) | 4 (22.2) | 14 (77.8) |
| High | 29 (35.4) | 53 (64.6) | 12 (14.6) | 70 (85.4) | 26 (31.7) | 56 (68.3) | 17 (20.7) | 65 (79.3) |
| P value | 0.012 | 0.426 | 0.893 | 0.888 | ||||
| Ki 67 level | ||||||||
| <40% | 2 (9.5) | 19 (90.5) | 8 (38.1) | 13 (61.9) | 8 (38.1) | 13 (61.9) | 6 (28.6) | 15 (71.4) |
| ≥40% | 29 (34.9) | 54 (65.1) | 10 (12.0) | 73 (88.0) | 25 (30.1) | 58 (69.9) | 16 (19.3) | 67 (80.7) |
| P value | 0.023 | 0.005 | 0.483 | 0.352 | ||||
| HER2 score | ||||||||
| 0 or 1 | 29 (32.2) | 61 (67.8) | 15 (16.7) | 75 (83.3) | 30 (33.3) | 60 (66,7) | 16 (17.8) | 74 (82.2) |
| 2 | 2 (14.3) | 12 (85.7) | 3 (21.4) | 11 (78.6) | 3 (21.4) | 11 (78.6) | 6 (42.9) | 8 (57.1) |
| P value | 0.172 | 0.661 | 0.373 | 0.033 | ||||